Comparison

LY2603618(IC-83)

Item no. DCC-DC7103-250mg
Manufacturer DCChemicals
CASRN 911222-45-2
Amount 250 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Inhibitors
Applications IC
Specific against other
Purity >98%
Smiles BrC1=C([H])C(=C(C([H])=C1C([H])([H])[H])OC([H])([H])[C@]1([H])C([H])([H])N([H])C([H])([H])C([H])([H])O1)N([H])C(N([H])C1C([H])=NC(C([H])([H])[H])=C([H])N=1)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias IC-83,LY 2603618,LY-2603618
Similar products 911222-45-2
Available
Manufacturer - Applications
LY2603618(IC-83) is a potent and selective small molecule inhibitor of Chk1 protein kinase activity in vitro (IC50=7 nM) and the first selective Chk1 inhibitor to enter clinical cancer trials.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
436, 303
Note
For research only, not for human use.
Chemical name
(S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close